Related Experiment Videos
A diabetes self-management program designed for urban American Indians
Sarah Castro1, Mary O'Toole, Carol Brownson
1Saint Louis University, Saint Louis, Missouri, USA. sbetsworth@gmail.com
Preventing Chronic Disease
|September 17, 2009
Summary
This study highlights the Full Circle Diabetes Program, a culturally sensitive approach to type 2 diabetes self-management for American Indians. The program significantly improved participants' knowledge of diabetes resources.
Area of Science:
- Public Health
- Health Disparities
- Indigenous Health
Background:
- American Indian populations experience disproportionately high rates of type 2 diabetes.
- Limited research exists on culturally sensitive diabetes self-management programs for this demographic.
- The Full Circle Diabetes Program was developed collaboratively to address these gaps.
Purpose of the Study:
- To develop and implement a culturally relevant diabetes self-management program for American Indians.
- To address barriers to diabetes self-management through a holistic approach.
- To evaluate the program's impact on participant knowledge and engagement.
Main Methods:
- The program integrated activities addressing holistic health: body, spirit, mind, and emotion.
- Services included exercise classes, educational sessions, and talking circles.
- Community and clinic partners collaborated to deliver program components.
Main Results:
- 98% of enrollees participated in at least one program activity.
- Two-thirds of participants engaged in two or more activities.
- Program participation led to significant improvements in knowledge of diabetes management resources.
Conclusions:
- The Full Circle Diabetes Program successfully provided culturally relevant diabetes self-management support.
- A holistic approach, community involvement, and stakeholder partnerships are crucial for program success.
- This model offers valuable insights for developing similar programs in Indigenous communities.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...